NCT06458400

To Evaluate the Efficacy and Safety of Tegileridine and Oliceridine Injections in the Treatment of Postoperative Pain

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 75 (actual)
• Sponsor: Yuwei Qiu · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This was a single-center, randomized, open-label, controlled exploratory study conducted in Chinese patients. The study planned to enroll Chinese patients to evaluate the efficacy and safety of tegileridine and oliceridine injection in the treatment of postoperative pain.

Conditions

• Analgesia

Interventions

Type	Name	Description
DRUG	Tegileridine	single dose+PCA dose
DRUG	Oliceridine	single dose+PCA dose
DRUG	Morphine	single dose+PCA dose

Timeline

• Start date: 2024-07-03
• Primary completion: 2024-09-30
• Completion: 2024-10-06
• First posted: 2024-06-13
• Last updated: 2025-01-01

Locations

1 site across 1 country: China